Literature DB >> 16698841

Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.

Michael Weber1, Christian Hamm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16698841      PMCID： PMC1860679          DOI： 10.1136/hrt.2005.071233

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  24 in total

1.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

Authors:  Charlotte Kragelund; Bjørn Grønning; Lars Køber; Per Hildebrandt; Rolf Steffensen
Journal:  N Engl J Med       Date:  2005-02-17       Impact factor: 91.245

2.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

3.  N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Christian W Hamm; Veselin Mitrovic; Nicte-Ha Lantelme; Harvey D White
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

4.  Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

Authors:  Franz Hartmann; Milton Packer; Andrew J S Coats; Michael B Fowler; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Alain Castaigne; Stefan D Anker; Ildiko Amann-Zalan; Silke Hoersch; Hugo A Katus
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

5.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

6.  Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.

Authors:  Jutta Bergler-Klein; Ursula Klaar; Maria Heger; Raphael Rosenhek; Gerald Mundigler; Harald Gabriel; Thomas Binder; Richard Pacher; Gerald Maurer; Helmut Baumgartner
Journal:  Circulation       Date:  2004-04-26       Impact factor: 29.690

7.  B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.

Authors:  A Mark Richards; M Gary Nicholls; Eric A Espiner; John G Lainchbury; Richard W Troughton; John Elliott; Christopher Frampton; John Turner; Ian G Crozier; Timothy G Yandle
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.

Authors:  Michael Weber; Thorsten Dill; Roman Arnold; Matthias Rau; Okan Ekinci; Klaus D Müller; Alexander Berkovitsch; Veselin Mitrovic; Christian Hamm
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749

9.  B-type natriuretic peptide in cardiovascular disease.

Authors:  James A de Lemos; Darren K McGuire; Mark H Drazner
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

10.  Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Authors:  Christian Mueller; André Scholer; Kirsten Laule-Kilian; Benedict Martina; Christian Schindler; Peter Buser; Matthias Pfisterer; André P Perruchoud
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245
View more
  111 in total

1.  Brain natriuretic peptide as a marker of cardiac toxicity in patients with multiple sclerosis treated with mitoxantrone.

Authors:  Pierluigi Bertora; Daniela Torzillo; Gabriella Baldi; Tarcisio Vago; Claudio Mariani
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

2.  Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population.

Authors:  Navin Suthahar; Wouter C Meijers; Jennifer E Ho; Ron T Gansevoort; Adriaan A Voors; Peter van der Meer; Stephan J L Bakker; Stephane Heymans; Vanessa van Empel; Blanche Schroen; Pim van der Harst; Dirk J van Veldhuisen; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2018-06-01       Impact factor: 15.534

Review 3.  Diverse molecular forms of plasma B-type natriuretic peptide in heart failure.

Authors:  Toshio Nishikimi; Naoto Minamino; Kazuwa Nakao
Journal:  Curr Heart Fail Rep       Date:  2011-06

4.  Cardiac troponin T elevations, using highly sensitive assay, in recreational running depend on running distance.

Authors:  Alma M A Mingels; Leo H J Jacobs; Vincent W Kleijnen; Eduard M Laufer; Bjorn Winkens; Leonard Hofstra; Will K W H Wodzig; Marja P van Dieijen-Visser
Journal:  Clin Res Cardiol       Date:  2010-03-08       Impact factor: 5.460

5.  Photonic Crystal-Enhanced Fluorescence Imaging Immunoassay for Cardiovascular Disease Biomarker Screening with Machine Learning Analysis.

Authors:  Kenneth J Squire; Yong Zhao; Ailing Tan; Kundan Sivashanmugan; Joseph A Kraai; Gregory L Rorrer; Alan X Wang
Journal:  Sens Actuators B Chem       Date:  2019-03-29       Impact factor: 7.460

Review 6.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

7.  Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.

Authors:  Petra G van Peet; Anton J M de Craen; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  Age (Dordr)       Date:  2014-05-08

8.  Surgical ventricular restoration to reverse left ventricular remodeling.

Authors:  Serenella Castelvecchio; Lorenzo Menicanti; Marisa Di Donato
Journal:  Curr Cardiol Rev       Date:  2010-02

9.  Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation.

Authors:  Dalit May; Dan Gilon; Valentin Djonov; Ahuva Itin; Alon Lazarus; Oren Gordon; Christian Rosenberger; Eli Keshet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

10.  Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Authors:  W T Longstreth; Richard A Kronmal; John L P Thompson; Robert H Christenson; Steven R Levine; Rebecca Gross; Robin L Brey; Richard Buchsbaum; Mitchell S V Elkind; David L Tirschwell; Stephen L Seliger; J P Mohr; Christopher R deFilippi
Journal:  Stroke       Date:  2013-01-22       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.